Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruchi Rani

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Virology|October 16, 2022
Multi-target direct-acting SARS-CoV-2 antivirals against the nucleotide-binding pockets of virus-specific proteinsRuchi Rani, Siwen Long, Akshay Pareek, et al.
International Journal of Biological Macromolecules|April 22, 2022
Characterization of a cytoplasmic 2-Cys peroxiredoxin from Citrus sinensis and its potential role in protection from oxidative damage and wound healingDeena Nath Gupta, Ruchi Rani, Amol D Kokane, et al.
ACS Infectious Diseases|March 7, 2025
Repurposing Efavirenz, the HIV Antiretroviral Drug for Chikungunya Virus InfectionSanketkumar Nehul, Ruchi Rani, Priyanshu Walia, et al.
Applied Biochemistry and Biotechnology|December 29, 2023
Comparative Analysis of Inhibitor Binding to Peroxiredoxins from Candidatus Liberibacter asiaticus and Its Host Citrus sinensisDeena Nath Gupta, Sapna Lonare, Ruchi Rani, et al.
Biochemistry|January 30, 2025
Structural and Mechanistic Insights into the Main Protease (Mpro) Dimer Interface Destabilization Inhibitor: Unveiling New Therapeutic Avenues against SARS-CoV-2Ankur Singh, Kuldeep Jangid, Sanketkumar Nehul, et al.
Biochemical and Biophysical Research Communications|June 16, 2024
Deciphering the drug delivery potential of Type1 lipid transfer protein from Citrus sinensis for enhancing the therapeutic efficacy of drugsSurabhi Rode, Harry Kaur, Ruchi Rani, et al.
Journal of Virology|February 27, 2026
The ORF6 accessory protein contributes to SARS-CoV-2 virulence and pathogenicity in the naturally susceptible feline model of infectionMohammed Nooruzzaman, Salman L Butt, Ruchi Rani, et al.
Contemporary Clinical Dentistry|June 8, 2018
An <i>In vitro</i> Comparison and Evaluation of Sealing Ability of Newly Introduced C-point System, Cold Lateral Condensation, and Thermoplasticized Gutta-Percha Obturating Technique: A Dye Extraction StudyTapati Manohar Sinhal, Ruchi Rani Purvesh Shah, Pratik Subhas Jais, et al.
NPJ Vaccines|January 12, 2026
Novel recombinant H5-based vaccine provides effective protection against H5N1 influenza virus in catsSalman L Butt, Pablo Sebastian Britto de Oliveira, Ruchi Rani, et al.
Viruses|May 25, 2024
Identification of an Immunodominant B-Cell Epitope in African Swine Fever Virus p30 Protein and Evidence of p30 Antibody-Mediated Antibody Dependent Cellular CytotoxicityJessica C G Noll, Ruchi Rani, Salman L Butt, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Virology|October 16, 2022
Multi-target direct-acting SARS-CoV-2 antivirals against the nucleotide-binding pockets of virus-specific proteinsRuchi Rani, Siwen Long, Akshay Pareek, et al.
International Journal of Biological Macromolecules|April 22, 2022
Characterization of a cytoplasmic 2-Cys peroxiredoxin from Citrus sinensis and its potential role in protection from oxidative damage and wound healingDeena Nath Gupta, Ruchi Rani, Amol D Kokane, et al.
ACS Infectious Diseases|March 7, 2025
Repurposing Efavirenz, the HIV Antiretroviral Drug for Chikungunya Virus InfectionSanketkumar Nehul, Ruchi Rani, Priyanshu Walia, et al.
Applied Biochemistry and Biotechnology|December 29, 2023
Comparative Analysis of Inhibitor Binding to Peroxiredoxins from Candidatus Liberibacter asiaticus and Its Host Citrus sinensisDeena Nath Gupta, Sapna Lonare, Ruchi Rani, et al.
Biochemistry|January 30, 2025
Structural and Mechanistic Insights into the Main Protease (Mpro) Dimer Interface Destabilization Inhibitor: Unveiling New Therapeutic Avenues against SARS-CoV-2Ankur Singh, Kuldeep Jangid, Sanketkumar Nehul, et al.
Biochemical and Biophysical Research Communications|June 16, 2024
Deciphering the drug delivery potential of Type1 lipid transfer protein from Citrus sinensis for enhancing the therapeutic efficacy of drugsSurabhi Rode, Harry Kaur, Ruchi Rani, et al.
Journal of Virology|February 27, 2026
The ORF6 accessory protein contributes to SARS-CoV-2 virulence and pathogenicity in the naturally susceptible feline model of infectionMohammed Nooruzzaman, Salman L Butt, Ruchi Rani, et al.
Contemporary Clinical Dentistry|June 8, 2018
An <i>In vitro</i> Comparison and Evaluation of Sealing Ability of Newly Introduced C-point System, Cold Lateral Condensation, and Thermoplasticized Gutta-Percha Obturating Technique: A Dye Extraction StudyTapati Manohar Sinhal, Ruchi Rani Purvesh Shah, Pratik Subhas Jais, et al.
NPJ Vaccines|January 12, 2026
Novel recombinant H5-based vaccine provides effective protection against H5N1 influenza virus in catsSalman L Butt, Pablo Sebastian Britto de Oliveira, Ruchi Rani, et al.
Viruses|May 25, 2024
Identification of an Immunodominant B-Cell Epitope in African Swine Fever Virus p30 Protein and Evidence of p30 Antibody-Mediated Antibody Dependent Cellular CytotoxicityJessica C G Noll, Ruchi Rani, Salman L Butt, et al.
Pageof 3